Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions., Vandevelde, N.M., Vermeersch Pieter, Devreese Katrien M. J., Vincent Marie-Françoise, Gulbis Béatrice, Eyskens François, Boemer François, Gothot André, Van Hoof Viviane O., Bonroy Carolien, et al. , Orphanet J Rare Dis, 2021 Feb 17, Volume 16, Issue 1, (2021)

Frequency of Participation in External Quality Assessment Programs Focused on Rare Diseases: Belgian Guidelines for Human Genetics Centers., Lantoine, Joséphine, Brysse Anne, Dideberg Vinciane, Claes Kathleen, Symoens Sofie, Coucke Wim, Benoit Valérie, Rombout Sonia, De Rycke Marine, Seneca Sara, et al. , JMIR Med Inform, 2021 Jul 12, Volume 9, Issue 7, (2021)

A pragmatic bottom-up approach to harmonize the units of clinical chemistry tests among Belgian clinical laboratories, focusing on immunoassays., Demarteau, Marianne, Cammaert Piet, Vandevelde N.M., Callewaert Nico, Coucke Wim, China Bernard, and Verstraete Alain G. , Clin Chem Lab Med, 2018 Dec 19, Volume 57, Issue 1, (2018)

Acceptance sampling theory applied to EQA sample homogeneity testing, Coucke, Wim, Bernard C., Demarteau M., Ghislain V, Lenga Yolande, Vandevelde N.M., Verbeke H., and Van Campenhout C. , EQALM Meeting 2015, 8/10/2015, Issue EQALM,  European Organisation For External Quality Assurance Providers in Laboratory Medicine, NA, (2015)

Belgian National Plan for Rare Diseases , Vandevelde, N.M. , International symposium Metabolics.be , 22/10/2015, Issue metabolics.be, (2015)

In vitro susceptibility of  S. pneumoniae  to solithromycin (SOL) in Belgian and German collections with an elevated percentage of isolates resistant to macrolides and fluoroquinolones., Tulkens, P.M., Van Bambeke F., Vandevelde N.M., Vanhoof R., and Van der Linden M. , 25 th  European Congress of Clinical Microbiology and Infectious Diseases., 0/0/2015, Issue XX, (2015)

Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: in vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes..., Vandevelde, N.M., Tulkens P.M., Diaz Iglesias Y., Verhaegen Jan, Rodriguez-Villalobos H., Philippart I., Cadrobbi J., Coppens N., Boel A., Van Vaerenbergh K., et al. , Int.J.Antimicrob.Agents, 0/9/2014, Volume 44, Issue 3, Number 217, p.209 - 217, (2014)